Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
52.80
-2.01 (-3.66%)
Mar 31, 2025, 1:37 PM EDT - Market open

Rhythm Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
130.1377.4323.643.15-
Upgrade
Revenue Growth (YoY)
68.06%227.56%649.46%--
Upgrade
Cost of Revenue
13.379.32.130.6-
Upgrade
Gross Profit
116.7668.1321.512.56-
Upgrade
Selling, General & Admin
144.3117.5392.0368.4946.13
Upgrade
Research & Development
237.96134.95108.63104.1390.45
Upgrade
Operating Expenses
382.26252.48200.66172.61136.58
Upgrade
Operating Income
-265.5-184.36-179.16-170.06-136.58
Upgrade
Interest Expense
-20.6-13.89-5.2--
Upgrade
Interest & Investment Income
14.7113.954.030.452.58
Upgrade
Other Non Operating Income (Expenses)
11.140.190.25100-
Upgrade
EBT Excluding Unusual Items
-260.26-184.11-180.08-69.61-134
Upgrade
Gain (Loss) on Sale of Investments
---1.04--
Upgrade
Pretax Income
-260.26-184.11-181.12-69.61-134
Upgrade
Income Tax Expense
0.350.56---
Upgrade
Net Income
-260.6-184.68-181.12-69.61-134
Upgrade
Preferred Dividends & Other Adjustments
3.97----
Upgrade
Net Income to Common
-264.57-184.68-181.12-69.61-134
Upgrade
Shares Outstanding (Basic)
6158525044
Upgrade
Shares Outstanding (Diluted)
6158525044
Upgrade
Shares Change (YoY)
5.76%10.65%5.08%12.40%21.15%
Upgrade
EPS (Basic)
-4.34-3.20-3.47-1.40-3.04
Upgrade
EPS (Diluted)
-4.34-3.20-3.47-1.40-3.04
Upgrade
Free Cash Flow
-113.88-136.2-173.71-146.44-122.19
Upgrade
Free Cash Flow Per Share
-1.87-2.36-3.33-2.95-2.77
Upgrade
Gross Margin
89.73%87.99%90.98%81.01%-
Upgrade
Operating Margin
-204.04%-238.10%-757.92%-5391.85%-
Upgrade
Profit Margin
-203.32%-238.52%-766.22%-2207.10%-
Upgrade
Free Cash Flow Margin
-87.51%-175.91%-734.87%-4642.90%-
Upgrade
EBITDA
-263.94-182.6-177.49-168.9-135.89
Upgrade
EBITDA Margin
-202.83%-235.83%---
Upgrade
D&A For EBITDA
1.561.761.671.160.69
Upgrade
EBIT
-265.5-184.36-179.16-170.06-136.58
Upgrade
EBIT Margin
-204.04%-238.10%---
Upgrade
Revenue as Reported
130.1377.4323.643.15-
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q